| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.02 |